COST

985.08

+0.04%↑

165.05

+2.64%↑

80.56

+0.91%↑

187.16

+2.03%↑

PEP

168.32

+2.09%↑

COST

985.08

+0.04%↑

165.05

+2.64%↑

80.56

+0.91%↑

187.16

+2.03%↑

PEP

168.32

+2.09%↑

COST

985.08

+0.04%↑

165.05

+2.64%↑

80.56

+0.91%↑

187.16

+2.03%↑

PEP

168.32

+2.09%↑

COST

985.08

+0.04%↑

165.05

+2.64%↑

80.56

+0.91%↑

187.16

+2.03%↑

PEP

168.32

+2.09%↑

COST

985.08

+0.04%↑

165.05

+2.64%↑

80.56

+0.91%↑

187.16

+2.03%↑

PEP

168.32

+2.09%↑

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Atidarymo kaina

21.97 1.38

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

21.15

Max

22.06

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	-22M 214M
P/E Sektoriaus vid.	23.222 32.9
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	-17M 11M

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-21

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	371K 382M
Ankstesnė atidarymo kaina	20.59
Ankstesnė uždarymo kaina	21.97

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-22 23:55; UTC

Rinkos pokalbiai

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

2026-02-22 23:53; UTC

Rinkos pokalbiai

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

2026-02-22 23:53; UTC

Rinkos pokalbiai

Key China Rates Likely to Be Held Steady for Now -- Market Talk

2026-02-22 23:51; UTC

Rinkos pokalbiai

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

2026-02-22 23:35; UTC

Rinkos pokalbiai

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

2026-02-22 23:21; UTC

Uždarbis

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

2026-02-22 23:20; UTC

Uždarbis

Nickel Industries 2025 Operating Profit US$126.4 Million

2026-02-22 23:19; UTC

Uždarbis

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

2026-02-22 23:19; UTC

Uždarbis

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

2026-02-22 23:18; UTC

Uždarbis

Nickel Industries Won't Pay a Final Dividend

2026-02-22 23:16; UTC

Uždarbis

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

2026-02-22 21:35; UTC

Uždarbis

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

2026-02-22 21:34; UTC

Uždarbis

Ampol Says F&I Australia, International Have Begun 2026 Strongly

2026-02-22 21:34; UTC

Uždarbis

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

2026-02-22 21:33; UTC

Uždarbis

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

2026-02-22 21:33; UTC

Uždarbis

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

2026-02-22 21:28; UTC

Uždarbis

Ampol Final Dividend A$0.60/Share

2026-02-22 21:28; UTC

Uždarbis

Ampol FY Revenue A$31.37 Billion, Down 10%

2026-02-22 21:28; UTC

Uždarbis

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

2026-02-22 21:28; UTC

Uždarbis

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

2026-02-21 14:31; UTC

Įsigijimai, susijungimai, perėmimai

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

2026-02-21 05:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-02-20 23:12; UTC

Įsigijimai, susijungimai, perėmimai

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

2026-02-20 22:12; UTC

Uždarbis

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

2026-02-20 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-20 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-02-20 21:23; UTC

Uždarbis

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

2026-02-20 21:20; UTC

Rinkos pokalbiai

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

2026-02-20 21:01; UTC

Įsigijimai, susijungimai, perėmimai

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

2026-02-20 20:38; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.